A pharmaceutical project includes an agile team of doctors who analyze human tissue scans from drug trial patients. The CEO wants to leverage Machine Learning (ML) technology, because it is proven to be faster and more accurate than doctors in scan analysis. How should the product owner proceed in response to the CEOs wish? Group of answer choices Anticipate a negative response from the team and be ready to persuade them that their time and skill will be better spent elsewhere. Work with the team to plan how to use the ML resources and produce a business case. Ask the team to produce a SWOT analysis supporting human-based validation. Record the risk in the register and plan for discussing a response in the retrospective.